Page last updated: 2024-08-24

3-iodobenzylguanidine and Blood Diseases

3-iodobenzylguanidine has been researched along with Blood Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kraal, KC; Tytgat, GA; van Dalen, EC; Van Eck-Smit, BL1
Siegel, JA; Sparks, RB; Stabin, MG1
Brophy, P; Cheng, SC; Goldsby, R; Hawkins, RA; Huberty, J; Kersun, LS; Maris, JM; Matthay, KK; Messina, J; Quach, A; Veatch, J; Yanik, G1
Jones, L; Nwosu, AC; Poston, GJ; Pritchard, DM; Vinjamuri, S; Vora, J1
Lasorella, A; Mancini, A; Mastrangelo, R; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L1
Diociaiuti, L; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L1
Glidden, DV; Hasegawa, B; Hawkins, RA; Huberty, J; Matthay, KK; Panina, C; Price, D; Tang, HR; Veatch, J1
Arrighini, A; Bertolazzi, L; Bestagno, M; Claudiani, F; De Bernardi, B; Garaventa, A; Guerra, P; Lanino, E; Villavecchia, GP1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Blood Diseases

ArticleYear
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
    The Cochrane database of systematic reviews, 2017, Apr-21, Volume: 4

    Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neuroblastoma; Observational Studies as Topic; Radiopharmaceuticals; Thyroid Diseases; Topotecan

2017

Trials

2 trial(s) available for 3-iodobenzylguanidine and Blood Diseases

ArticleYear
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Mar-20, Volume: 25, Issue:9

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iodine Radioisotopes; Kaplan-Meier Estimate; Logistic Models; Lymph Node Excision; Neoplasm Staging; Neuroblastoma; Radiation Injuries; Radiopharmaceuticals; Time Factors; Treatment Failure; Treatment Outcome; United States

2007
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:11

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Algorithms; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Neuroblastoma; Radiometry; Radiopharmaceuticals; Whole-Body Counting

2001

Other Studies

5 other study(ies) available for 3-iodobenzylguanidine and Blood Diseases

ArticleYear
Total-body and red marrow dose estimates.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:2

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Algorithms; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Neuroblastoma; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage

2003
Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours.
    British journal of cancer, 2008, Mar-25, Volume: 98, Issue:6

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Hematologic Diseases; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Radiopharmaceuticals; Survival Analysis

2008
A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:4

    Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Hematologic Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pilot Projects

1995
Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Hematologic Diseases; Hemorrhage; Humans; Infant; Infections; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction

1995
Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine.
    Cancer, 1991, Feb-15, Volume: 67, Issue:4

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radiotherapy Dosage; Recurrence

1991